Content
11/02/2021
San Diego, CA USA
Biolinq
completed $100 million Series B Round funding. Investors include
RiverVest Venture Partners (lead), AXA Investment Managers, Global Health Investment Corporation, Longevity Vision Fund, Alpha Wave Global, Aphelion Capital, M Ventures, Hikma Ventures, Senvest Management, Able Partners.
About
Biolinq is a healthcare technology company pioneering precision multi-analyte wearable sensors to improve metabolic health. The company’s biosensor platform is designed to inform and inspire with unparalleled simplicity to support healthier living. With microsensors that reside just below the skin's surface, Biolinq is redefining the future of continuous biosensing. The company is headquartered in San Diego, CA.
Startup
Sector:
IoT
MedTech
Healthcare
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
